MarketInOut Stock Screener Log In | Sign Up
 

Neuronetics Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Neuronetics Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization162.68 mln
Float28.88 mln
Earnings Date11/04/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.27
Reliable

Relative Strength

55 / 100
Slightly ahead

Debt / Equity

4.85
Highly leveraged

Pre-Tax Margin

-20%
Loss-making

ROE

-141
Deeply negative

Business Description

Neuronetics develops and sells a specialized medical device called the NeuroStar Advanced Therapy System, which helps adults suffering from major depression. The technology works by using magnetic pulses to gently stimulate targeted regions of the brain linked to mood, offering an alternative to medication-based treatments. Founded in 2001 and based in Malvern, Pennsylvania, the company markets its system directly to psychiatrists across the United States and in other countries.

Key Fundamentals

EPS-0.43
ROE-141
RPS2.22
ROIC-23.74
ROA-22.42
Interest Cover-2.67
EBITDA, mln-18.81
EV / EBITDA-12.73
EV / EBIT-10.92
Revenue, mln155
EV / Revenue1.54

Quote Details

Last 2.11
Change 0.03 (1.44%)
Open 2.08
Volume 600,333
Turnover 1,266,703
Average Volume 739,037

Financial Ratios

Pre-Tax Profit Margin-20
Leverage Ratio7.37
Current Ratio1.88
Price / Book8.36
Debt / Equity4.85
Price / Sales1.03

Financial Strength

Altman Z-Score-3.2
Piotroski F-Score 4 / 9
Beneish M-Score-3.27
Short Ratio5.64
Short % of Float17.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.64% 95 / 100   
1 Month -25.18% 14 / 100   
2 Months 4.46% 81 / 100   
6 Months 25.6% 91 / 100   
1 Year -27.99% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog